Cargando…
Identification of metabolic biomarkers in patients with type 2 diabetic coronary heart diseases based on metabolomic approach
Type 2 diabetic coronary heart disease (T2DM-CHD) is a kind of serious and complex disease. Great attention has been paid to exploring its mechanism; however, the detailed understanding of T2DM-CHD is still limited. Plasma samples from 15 healthy controls, 13 coronary heart disease (CHD) patients, 1...
Autores principales: | Liu, Xinfeng, Gao, Jian, Chen, Jianxin, Wang, Zhiyong, Shi, Qi, Man, Hongxue, Guo, Shuzhen, Wang, Yingfeng, Li, Zhongfeng, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965763/ https://www.ncbi.nlm.nih.gov/pubmed/27470195 http://dx.doi.org/10.1038/srep30785 |
Ejemplares similares
-
Study on Qi Deficiency Syndrome Identification Modes of Coronary Heart Disease Based on Metabolomic Biomarkers
por: Shi, Qi, et al.
Publicado: (2014) -
Toxicological Risks of Renqingchangjue in Rats Evaluated
by (1)H NMR-Based Serum and Urine Metabolomics Analysis
por: Wang, Xia, et al.
Publicado: (2020) -
Metabolomics-Based Study of Clinical and Animal Plasma Samples in Coronary Heart Disease with Blood Stasis Syndrome
por: Zhao, Huihui, et al.
Publicado: (2012) -
(1)H NMR-Based Metabolomics Study of the Toxicological Effects in Rats Induced by “Renqing Mangjue” Pill, a Traditional Tibetan Medicine
por: Xu, Can, et al.
Publicado: (2017) -
Tissue metabolomics study to reveal the toxicity of a traditional Tibetan medicine ‘Renqing Changjue’ in rats
por: Xu, Can, et al.
Publicado: (2018)